Reverse Transcriptase Inhibitors: all 1,328 studies that test it
Page 7 of 14. Open to participants first (42), then studies with results posted, then the rest; newest registration first within each.
- Study to Determine the Effect of Efavirenz on the ECG QTcF Interval in Healthy SubjectsCompletedNCT02164812Phase 1
- Study to Evaluate Darunavir/Ritonavir + Lamivudine Versus Continuing With Darunavir/Ritonavir + Tenofovir/Emtricitabine or Abacavir/Lamivudine in HIV Infected SubjectCompletedNCT02159599Phase 4
- Efficacy and Safety of Foscarnet Sodium and Sodium Chloride Injection in Patients With Herpes ZosterCompletedNCT02151240Phase 4
- PRe-Exposure Prophylaxis Acceptability & Readiness Assessments for Toronto gaY, Bisexual and Other Men Who Have Sex With Men-5CompletedNCT02149888Phase 4
- Demonstrating Safety and Effective Delivery of Daily Oral Pre-exposure Prophylaxis (PrEP) for Sex Workers in IndiaCompletedNCT02148094Early Phase 1
- Switch From Nevirapine-based Regimen to Once a Day Rilpivirine/Emtricitabine/TenofovirCompletedNCT02104700Phase 2/3
- Study of Recovery of Intestinal CD4+ and Th17 T Cells in HIV-infected Individuals on Short-term Antiretroviral TherapyStatus unknownNCT02097381Not applicable
- Tenofovir Abacavir Platelet Activation StudyCompletedNCT02093585Phase 4
- Multicentric Open-label Study of Switch From Abacavir/Lamivudine Fixed Dose Combination Plus Nevirapine to Abacavir/Lamivudine/Dolutegravir in Virologically Suppressed HIV-1 Infected Adults (SWAD)CompletedNCT02067767Phase 2
- DDI Study of BMS-663068 With Etravirine (ETR) and/or Darunavir (DVR) + Ritonavir (RTV)CompletedNCT02063360Phase 1
- Prevention of Hepatitis B Virus Vertical Transmission by Serovaccination and Tenofovir During PregnancyCompletedNCT02039362Phase 4
- A Feasibility Study to Assess Tenofovir and Maraviroc Protection Against HIV-1 in Cervical and Vaginal ExplantsCompletedNCT02039323Phase 1
- Therapeutic Exploratory Phase 2 Study to Evaluate the Safety and Efficacy of MB12066 in Patients With Nonalcoholic Fatty Liver Disease(NAFLD) Except CirrhosisTerminatedNCT02029586Phase 2
- Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIVActive, not recruitingNCT02016924Phase 2/3
- Implementation of the Pre-Exposure Prophylaxis (PrEP) to HIV: A Demonstrative Project.Status unknownNCT01989611Not applicable
- Safety, Tolerability, Drug Interactions, and Antiviral Activity of Rilpivirine in Antiretroviral-Naive HIV-Infected Children Less Than 12 Years of AgeWithdrawnNCT01975012Phase 1/2
- Safety and Efficacy Double Blind Vehicle Controlled Study of 15% AS101 Gel to Treat External Genital WartsStatus unknownNCT01943630Phase 2
- LAAM-HAART PET ImagingCompletedNCT01935830Early Phase 1
- A Randomized Controlled Trial on the Efficacy of Tenofovir Disoproxil Fumarate (TDF)-Switch Therapy in Chronic Hepatitis B Patients With Incomplete Response to EntecavirCompletedNCT01918631Not applicable
- Entecavir Versus Lamivudine for Preventing the Risk of Hepatitis B Reactivation in NHLStatus unknownNCT01914744Phase 2
- A Prospective, Open-label Trial of Two ABC/3TC Based Regimens in Late Presenter naïve Patients (CD4 <200 Cells/µL)CompletedNCT01900106Phase 3
- Changes in Liver Steatosis After Switching to Raltegravir in HIV/HCV CoinfectionCompletedNCT01900015Phase 4
- Chemoembolization With or Without Antiviral Therapy for Unresectable HBV-related HCC With Low HBV DNA ReplicationStatus unknownNCT01894269Phase 4
- Determining the Effect of Abacavir on Platelet ActivationCompletedNCT01886638Phase 4
- Interaction Between Etravirine or Darunavir/Ritonavir and Artemether / LumefantrineCompletedNCT01876966Phase 1
- Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular CarcinomaTerminatedNCT01872988Phase 3
- Tenofovir Versus Lamivudine for Patients of Chronic Hepatitis B With Severe Acute ExacerbationStatus unknownNCT01848743Phase 3
- SCOPE: Strategies to Combine PrEP With Prevention EffortsWithdrawnNCT01832571Not applicable
- Efficacy Optimizing Extension Study of Chronic Hepatitis B Patients With Inadequate Response to NUC TherapyStatus unknownNCT01829685Phase 4
- In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal ProductsCompletedNCT01813162Phase 1
- Efficacy and Safety of Concomitant Use of Nevirapine and Rifampicin With HIV-TBCompletedNCT01805258Phase 3
- Comparison of Telbivudine Plus Adefovir With Lamivudine Plus Adefovir for the Treatment of Lamivudine-resistant Chronic Hepatitis B at 52 Weeks: A Pilot StudyStatus unknownNCT01804387Phase 4
- A Single-Dose Pharmacokinetics and Safety Study of TMC278 in Healthy Adult Japanese ParticipantsCompletedNCT01804244Phase 4
- Telbivudine Renoprotective Effect in Patients With the HBV-related Liver Cirrhosis: a Randomized Controlled TrialStatus unknownNCT01799486Phase 4
- Pharmacokinetics of Tenofovir and Tenofovir-diphosphate, Emtricitabine and Emtricitabine-triphosphate, and Rilpivirine Once Daily Over 14 Days Following Drug Intake Cessation in Healthy VolunteersCompletedNCT01796431Phase 1
- A Pharmacokinetic Evaluation of Levonorgestrel Implant and Antiretroviral TherapyCompletedNCT01789879Phase 2
- Nucleoside Analogue Prevent Vertical Transmission of Hepatitis B VirusCompletedNCT01788371Phase 4
- Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a Resource Limited SettingCompletedNCT01772940Phase 4
- Study of Telbivudine and Lamivudine to Prevent Vertical Transmission of Hepatitis BCompletedNCT01743079Phase 4
- A Phase IV, Open-label Single-arm Study Investigating the Pharmacokinetics and Pharmacodynamics of the Antiretroviral Combination of Rilpivirine and Ritonavirboosted Darunavir in Therapy-naive HIV-1 Infected Patients.CompletedNCT01736761Phase 4
- TDF VS LAM + ADV in LAM + ADV Treated LAM-resistant CHB Patients With Undetectable Hepatitis B Virus DNACompletedNCT01732367Phase 4
- To Compare the Efficacy of Combined Tenofovir Plus Telbivudine vs Tenofovir Alone in Patients With Spontaneous Reactivation of Hepatitis BCompletedNCT01732224Not applicable
- Tenofovir in Asian Chronic Hepatitis B PatientsCompletedNCT01728935Not applicable
- A Study to Explore Pharmacokinetic Interaction Between Rilpivirine and Metformin in Healthy ParticipantsCompletedNCT01719614Phase 1
- Safety, Tolerability,and Adherence to Co-formulated Tenofovir-emtricitabine-rilpivirine Used as HIV Nonoccupational Post-exposure Prophylaxis in Men Who Have Sex With Men.CompletedNCT01715636Phase 4
- Tenofovir Disoproxil Fumarate vs. Entecavir in Chronic Hepatitis B Patients With Partial Virologic Response to EntecavirCompletedNCT01711567Phase 4
- A Pilot Study to Assess the Feasibility of Switching, Individuals Receiving Atripla With Continuing Central Nervous System (CNS) Toxicity, to a Fixed Dose Combination of Tenofovir/Emtricitabine/RilpivirineCompletedNCT01701882Phase 3
- A Pilot Study on Raltegravir, Tenofovir and Emtricitabine for Peri-exposure Prophylaxis for HIV InfectionStatus unknownNCT01697046Phase 3
- Economic, Clinical and Quality of Life Assessment in Patients on Antiretroviral TherapyCompletedNCT01694017Phase 4
- Interaction Study to Assess the Pharmacokinetic Interaction of Oral Administration of Rifapentine on ATRIPLA™ in HIV PatientsCompletedNCT01690403Phase 1
- Coital Pharmacokinetics/Pharmacodynamics (PK/PD) of Tenofovir GelCompletedNCT01687205Phase 1
- A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis BCompletedNCT01671787Phase 1
- Abacavir and Lamivudine PK in ChildrenCompletedNCT01656122Phase 2/3
- A Study to Evaluate Safety, Acceptability, Pharmacokinetics, and ex Vivo Pharmacodynamics of TMC278 Long Acting Formulation in HIV-1 Seronegative ParticipantsCompletedNCT01656018Phase 1
- BREATHER (PENTA 16) Short-Cycle Therapy (SCT) (5 Days on/2 Days Off) in Young People With Chronic HIV-infectionStatus unknownNCT01641016Phase 2/3
- Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study)CompletedNCT01637558Phase 4
- MARCH Renal SubstudyCompletedNCT01637259Phase 4
- Comparison Between Lamivudine and Entecavir Treatment in Spontaneous Severe Acute ExacerbationTerminatedNCT01627223Phase 4
- Evaluation of the Bioequivalence of a Combined Formulated TabletCompletedNCT01622790Phase 1
- A Study to Explore the Pharmacokinetics of Rilpivirine With Rifabutin in Healthy ParticipantsCompletedNCT01615614Phase 1
- Highly Active Antiretroviral Therapy for Patients With Primary Biliary CirrhosisTerminatedNCT01614405Not applicable
- Differences Between Stavudine and Tenofovir Each Combined With Lamivudine and Efavirenz in SA HIV-infected PatientsTerminatedNCT01601899Phase 4
- Atazanavir/r + Lamivudine Dual TherapyCompletedNCT01599364Phase 4
- Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus InfectionStatus unknownNCT01594905Phase 4
- A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Repeat Dose Administration of Long-Acting GSK1265744 and Long-Acting TMC278 Intramuscular and Subcutaneous Injections in Healthy Adult SubjectsCompletedNCT01593046Phase 1
- A Study of Drug-Drug Interaction Between Danoprevir Coadministered With Low-Dose Ritonavir and Tenofovir Disoproxil Fumarate or AtazanavirCompletedNCT01592305Phase 1
- Efficacy of Telbivudine With or Without add-on Tenofovir According to Roadmap Strategy Compare With EntecavirStatus unknownNCT01588912Phase 4
- A Study of Potential Drug-Drug Interaction Between Efavirenz and Danoprevir With Low Dose Ritonavir in Healthy VolunteersCompletedNCT01588002Phase 1
- The Mochudi Prevention Project ART ProtocolTerminatedNCT01583439Not applicable
- A Clinical Trial to Investigate the Pharmacokinetic Drug-drug Interaction of Clevudine and Adefovir Dipivoxil After Oral Administration in Healthy Male SubjectsCompletedNCT01581242Phase 1
- Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir (RAL-PEP)CompletedNCT01576731Phase 4
- Evaluating the Safety and Drug Interaction of PA-824, an Investigational Tuberculosis Medication, Together With Efavirenz, Ritonavir-Boosted Lopinavir, or RifampinCompletedNCT01571414Phase 1
- Gender-Specific Combination HIV Prevention for Youth in High Burden Settings (MP3-Youth)CompletedNCT01571128Not applicable
- Safety and Efficacy Study to Test Topical AS101 for External Genital WartsCompletedNCT01555112Phase 1/2
- Adefovir and Lamivudine for Entecavir Resistance (ALTER Study)CompletedNCT01546116Phase 4
- Safety of Reduced Dose Zidovudine (AZT) Compared With Standard Dose AZT in Antiretroviral-naïve HIV-infected PatientsStatus unknownNCT01540240Phase 2/3
- Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1:FOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC (MARAVI-PEP)CompletedNCT01533272Phase 4
- Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in LymphomaWithdrawnNCT01528865Phase 1/2
- Tenofovir in Chronic Hepatitis B With Mild ALT ElevationCompletedNCT01522625Phase 4
- A Two-year Study of Telbivudine in HBeAg Negative HepatitisCompletedNCT01521975Phase 4
- A Study to Investigate the Effect of Steady-State TMC278 on the Pharmacokinetics of a Single Dose of DigoxinCompletedNCT01519128Phase 1
- The Neurocognitive Sub-study of Encore1CompletedNCT01516060Phase 3
- Effect of HAART Vs. Statin Treatment on Endothelial Function and Inflammation/CoagulationWithdrawnNCT01515813Phase 2
- Perinatal Antiretroviral Intensification for PMTCT of HIV in Late ComersCompletedNCT01511237Phase 3
- Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B PatientsStatus unknownNCT01491295Phase 4
- Evaluating the Safety of Tenofovir Vaginal Gel in HIV-Uninfected Pregnant WomenWithdrawnNCT01490671Phase 2
- Safety, Efficacy and Dose-response Study of BMS-986001 in Subjects With HIV-1 Infection Who Are Treatment-naiveTerminatedNCT01489046Phase 2
- Pharmacokinetic (PK) Profiles of Tenofovir Disoproxil Fumarate (TDF) 300 mg in Healthy Chinese SubjectsCompletedNCT01480622Phase 1
- On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With MenCompletedNCT01473472Phase 3
- Bioequivalence Study of Pediatric Formulations to Treat HIV InfectionStatus unknownNCT01469520Phase 1
- Trial To Assess The Lipid-Lowering Effect Of Adding Tenofovir/Emtricitabine Co-Formulation Vs Placebo To Hiv-1-Infected Subjects With Dyslipidemia And Sustained Viral Load Suppression Under Monotherapy With Ritonavir-Boosted Protease InhibitorsCompletedNCT01458977Phase 4
- The Efavirenz (EFV) Central Nervous System Exposure Sub-study of Encore1CompletedNCT01451333Phase 3
- A Study on Antiretroviral Therapy (ART) Naïve Patients On Different Regimens to Treat Hiv (NORTHIV)CompletedNCT01445223Phase 4
- Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy VolunteersCompletedNCT01444677Phase 1
- Study of Effects and Safety Between Adefovir Dipivoxil Plus Polyene Phosphatidylcholine Versus Adefovir Dipivoxil Alone in Chronic Hepatitis B PatientsStatus unknownNCT01436539Phase 4
- A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Etravirine Administered in Combination With Other Antiretroviral Agents in Antiretroviral Treatment-Experienced HIV-1 Infected PatientsCompletedNCT01422330Phase 4
- Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) InfectionCompletedNCT01386294Phase 3
- Efficacy and Safety of Oltipraz in the Patients With Non-alcoholic Fatty Liver DiseaseCompletedNCT01373554Phase 2
- Pharmacokinetic and Pharmacodynamic Study of Tenofovir 1% GelCompletedNCT01369303Phase 1
- Two Clinical Trials to Evaluate Pharmacokinetics of Unboosted and Boosted Atazanavir Used Alone or Co-administered With Tenofovir DF in Healthy Korean and Caucasian Male VolunteersStatus unknownNCT01368783Phase 1